Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
570
mi
from 91732
Salt Lake City, UT
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
570
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
570
mi
from 91732
Salt Lake City, UT
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
570
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
2510
mi
from 91732
White River Junction, VT
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
2510
mi
from 91732
White River Junction, VT
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
965
mi
from 91732
Seattle, WA
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
965
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
965
mi
from 91732
Seattle, WA
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
965
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
1653
mi
from 91732
Madison, WI
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative site
1653
mi
from 91732
Madison, WI
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
1653
mi
from 91732
Madison, WI
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative site
1653
mi
from 91732
Madison, WI
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
1728
mi
from 91732
Milwaukee, WI
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigator Site
1728
mi
from 91732
Milwaukee, WI
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
417
mi
from 91732
Tucson, AZ
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
417
mi
from 91732
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
2486
mi
from 91732
New Haven, CT
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
2486
mi
from 91732
New Haven, CT
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
1728
mi
from 91732
Evanston, IL
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
1728
mi
from 91732
Evanston, IL
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
1723
mi
from 91732
Hazel Crest, IL
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
1723
mi
from 91732
Hazel Crest, IL
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
2612
mi
from 91732
Portland, ME
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
2612
mi
from 91732
Portland, ME
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
2515
mi
from 91732
Lebanon, NH
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
2515
mi
from 91732
Lebanon, NH
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
2434
mi
from 91732
Brooklyn, NY
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
2434
mi
from 91732
Brooklyn, NY
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
2442
mi
from 91732
Flushing, NY
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
2442
mi
from 91732
Flushing, NY
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
2562
mi
from 91732
Providence, RI
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative site
2562
mi
from 91732
Providence, RI
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
2267
mi
from 91732
Richmond, VA
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
2267
mi
from 91732
Richmond, VA
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
6113
mi
from 91732
Caba,
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
6113
mi
from 91732
Caba,
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
1485
mi
from 91732
Saint Cloud, MN
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
1485
mi
from 91732
Saint Cloud, MN
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
1515
mi
from 91732
Saint Paul, MN
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
1515
mi
from 91732
Saint Paul, MN
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
2441
mi
from 91732
Bronx, NY
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
2441
mi
from 91732
Bronx, NY
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
25
mi
from 91732
Los Angeles, CA
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative site
25
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
2485
mi
from 91732
West Haven, CT
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
2485
mi
from 91732
West Haven, CT
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
1562
mi
from 91732
Saint Louis, MO
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
1562
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
2306
mi
from 91732
Lake Worth, FL
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
2306
mi
from 91732
Lake Worth, FL
Click here to add this to my saved trials
Bicuspid Valve Aortopathy Feasibility Study
Bicuspid Valve Aortopathy: Feasibility of a Comparative Effectiveness Study
Status: Enrolling
Updated:  12/31/1969
13
mi
from 91732
Los Angeles, CA
Bicuspid Valve Aortopathy Feasibility Study
Bicuspid Valve Aortopathy: Feasibility of a Comparative Effectiveness Study
Status: Enrolling
Updated: 12/31/1969
University of California
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Bicuspid Valve Aortopathy Feasibility Study
Bicuspid Valve Aortopathy: Feasibility of a Comparative Effectiveness Study
Status: Enrolling
Updated:  12/31/1969
817
mi
from 91732
Denver, CO
Bicuspid Valve Aortopathy Feasibility Study
Bicuspid Valve Aortopathy: Feasibility of a Comparative Effectiveness Study
Status: Enrolling
Updated: 12/31/1969
University of Colorado
817
mi
from 91732
Denver, CO
Click here to add this to my saved trials
Bicuspid Valve Aortopathy Feasibility Study
Bicuspid Valve Aortopathy: Feasibility of a Comparative Effectiveness Study
Status: Enrolling
Updated:  12/31/1969
827
mi
from 91732
Portland, OR
Bicuspid Valve Aortopathy Feasibility Study
Bicuspid Valve Aortopathy: Feasibility of a Comparative Effectiveness Study
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
827
mi
from 91732
Portland, OR
Click here to add this to my saved trials
Bicuspid Valve Aortopathy Feasibility Study
Bicuspid Valve Aortopathy: Feasibility of a Comparative Effectiveness Study
Status: Enrolling
Updated:  12/31/1969
2295
mi
from 91732
Hershey, PA
Bicuspid Valve Aortopathy Feasibility Study
Bicuspid Valve Aortopathy: Feasibility of a Comparative Effectiveness Study
Status: Enrolling
Updated: 12/31/1969
Penn State
2295
mi
from 91732
Hershey, PA
Click here to add this to my saved trials
Bicuspid Valve Aortopathy Feasibility Study
Bicuspid Valve Aortopathy: Feasibility of a Comparative Effectiveness Study
Status: Enrolling
Updated:  12/31/1969
1357
mi
from 91732
Houston, TX
Bicuspid Valve Aortopathy Feasibility Study
Bicuspid Valve Aortopathy: Feasibility of a Comparative Effectiveness Study
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Bicuspid Valve Aortopathy Feasibility Study
Bicuspid Valve Aortopathy: Feasibility of a Comparative Effectiveness Study
Status: Enrolling
Updated:  12/31/1969
1919
mi
from 91732
Atlanta, GA
Bicuspid Valve Aortopathy Feasibility Study
Bicuspid Valve Aortopathy: Feasibility of a Comparative Effectiveness Study
Status: Enrolling
Updated: 12/31/1969
Emory University
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Bioresorbable Vascular Scaffold, in the Treatment of Subjects With de Novo Native Coronary Artery Lesions in Chinese Population
Status: Enrolling
Updated:  12/31/1969
318
mi
from 91732
Santa Clara, CA
A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Bioresorbable Vascular Scaffold, in the Treatment of Subjects With de Novo Native Coronary Artery Lesions in Chinese Population
Status: Enrolling
Updated: 12/31/1969
Abbott Vascular
318
mi
from 91732
Santa Clara, CA
Click here to add this to my saved trials
Diffuse Myocardial Fibrosis in Fontan Patients
Heart Failure and Fibrosis in Adult Congenital Heart Patients With a Single Ventricle and Prior Fontan Operation.
Status: Enrolling
Updated:  12/31/1969
827
mi
from 91732
Portland, OR
Diffuse Myocardial Fibrosis in Fontan Patients
Heart Failure and Fibrosis in Adult Congenital Heart Patients With a Single Ventricle and Prior Fontan Operation.
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
827
mi
from 91732
Portland, OR
Click here to add this to my saved trials
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated:  12/31/1969
13
mi
from 91732
Los Angeles, CA
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated:  12/31/1969
2316
mi
from 91732
Miami, FL
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated: 12/31/1969
Baptist Hospital of Miami, FL
2316
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated:  12/31/1969
2205
mi
from 91732
Charlottesville, VA
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated: 12/31/1969
University of Virginia Health System
2205
mi
from 91732
Charlottesville, VA
Click here to add this to my saved trials
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated:  12/31/1969
323
mi
from 91732
Mountain View, CA
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated: 12/31/1969
El Camino Hospital
323
mi
from 91732
Mountain View, CA
Click here to add this to my saved trials
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated:  12/31/1969
366
mi
from 91732
Sacramento, CA
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated: 12/31/1969
University of California, Davis Medical Center
366
mi
from 91732
Sacramento, CA
Click here to add this to my saved trials
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated:  12/31/1969
825
mi
from 91732
Aurora, CO
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated: 12/31/1969
University of Colorado Health Sciences Ctr.
825
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated:  12/31/1969
2281
mi
from 91732
Washington,
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated: 12/31/1969
MedStar Washington Hospital Center
2281
mi
from 91732
Washington,
Click here to add this to my saved trials
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated:  12/31/1969
1918
mi
from 91732
Atlanta, GA
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated: 12/31/1969
Piedmont Hospital
1918
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated:  12/31/1969
1920
mi
from 91732
Atlanta, GA
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated: 12/31/1969
St. Joseph's Hospital
1920
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated:  12/31/1969
1726
mi
from 91732
Chicago, IL
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
1726
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated:  12/31/1969
1728
mi
from 91732
Evanston, IL
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated: 12/31/1969
Evanston Hospital
1728
mi
from 91732
Evanston, IL
Click here to add this to my saved trials
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated:  12/31/1969
1793
mi
from 91732
Indianapolis, IN
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated: 12/31/1969
The Care Group Medical Center (St. Vincent Hospital)
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated:  12/31/1969
1335
mi
from 91732
Shawnee Mission, KA
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated: 12/31/1969
Shawnee Mission Medical Center
1335
mi
from 91732
Shawnee Mission, KA
Click here to add this to my saved trials
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated:  12/31/1969
1626
mi
from 91732
Houma, LA
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated: 12/31/1969
Terrebonne General Medical Center
1626
mi
from 91732
Houma, LA
Click here to add this to my saved trials
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated:  12/31/1969
2614
mi
from 91732
Portland, ME
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated: 12/31/1969
Maine Medical Center
2614
mi
from 91732
Portland, ME
Click here to add this to my saved trials
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated:  12/31/1969
1960
mi
from 91732
Royal Oak, MI
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)
Status: Enrolling
Updated: 12/31/1969
William Beaumont Hospital
1960
mi
from 91732
Royal Oak, MI
Click here to add this to my saved trials